ARCHIVES

DRG Regulation Opponents May Have Powerful New Ally

This article is from The Cancer Letter archive.

Vol. 09 No. 45 | November 25, 1983

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

October 29, 2004

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

Possible Association Between Agent Orange, AML, IOM Says.

April 27, 2001

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007